These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 28651788)

  • 1. Mechanistic Target of Rapamycin-Independent Antidepressant Effects of (R)-Ketamine in a Social Defeat Stress Model.
    Yang C; Ren Q; Qu Y; Zhang JC; Ma M; Dong C; Hashimoto K
    Biol Psychiatry; 2018 Jan; 83(1):18-28. PubMed ID: 28651788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model.
    Yang C; Qu Y; Fujita Y; Ren Q; Ma M; Dong C; Hashimoto K
    Transl Psychiatry; 2017 Dec; 7(12):1294. PubMed ID: 29249803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of rapid antidepressant effects of Kir4.1 channel inhibitors in a chronic social defeat stress model: Comparison with (R)-ketamine.
    Xiong Z; Zhang K; Ishima T; Ren Q; Ma M; Pu Y; Chang L; Chen J; Hashimoto K
    Pharmacol Biochem Behav; 2019 Jan; 176():57-62. PubMed ID: 30502360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine.
    Yao W; Cao Q; Luo S; He L; Yang C; Chen J; Qi Q; Hashimoto K; Zhang JC
    Mol Psychiatry; 2022 Mar; 27(3):1618-1629. PubMed ID: 34819637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Inflammatory Bone Markers in the Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model.
    Zhang K; Ma M; Dong C; Hashimoto K
    Int J Neuropsychopharmacol; 2018 Nov; 21(11):1025-1030. PubMed ID: 30032169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
    Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxytryptamine-Independent Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model.
    Zhang K; Dong C; Fujita Y; Fujita A; Hashimoto K
    Int J Neuropsychopharmacol; 2018 Feb; 21(2):157-163. PubMed ID: 29155989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of mTOR dependent signaling pathway is a necessary mechanism of antidepressant-like activity of zinc.
    Szewczyk B; Pochwat B; Rafało A; Palucha-Poniewiera A; Domin H; Nowak G
    Neuropharmacology; 2015 Dec; 99():517-26. PubMed ID: 26297535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of metabolism in (R)-ketamine's antidepressant actions in a chronic social defeat stress model.
    Zhang K; Fujita Y; Hashimoto K
    Sci Rep; 2018 Mar; 8(1):4007. PubMed ID: 29507385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms underlying the rapid-acting antidepressant-like effects of neuropeptide VGF (non-acronymic) C-terminal peptide TLQP-62.
    Lv D; Chen Y; Shen M; Liu X; Zhang Y; Xu J; Wang C
    Neuropharmacology; 2018 Dec; 143():317-326. PubMed ID: 30291938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of Antidepressant Effects of Low-Voltage-Sensitive T-Type Calcium Channel Blocker Ethosuximide in a Chronic Social Defeat Stress Model: Comparison with (R)-Ketamine.
    Tian Z; Dong C; Zhang K; Chang L; Hashimoto K
    Int J Neuropsychopharmacol; 2018 Nov; 21(11):1031-1036. PubMed ID: 30085247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice.
    Shen M; Lv D; Liu X; Li S; Chen Y; Zhang Y; Wang Z; Wang C
    Brain Res Bull; 2018 Oct; 143():58-65. PubMed ID: 30316917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model.
    Zhang K; Toki H; Fujita Y; Ma M; Chang L; Qu Y; Harada S; Nemoto T; Mizuno-Yasuhira A; Yamaguchi JI; Chaki S; Hashimoto K
    Psychopharmacology (Berl); 2018 Nov; 235(11):3177-3185. PubMed ID: 30215218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine.
    Yang C; Kobayashi S; Nakao K; Dong C; Han M; Qu Y; Ren Q; Zhang JC; Ma M; Toki H; Yamaguchi JI; Chaki S; Shirayama Y; Nakazawa K; Manabe T; Hashimoto K
    Biol Psychiatry; 2018 Oct; 84(8):591-600. PubMed ID: 29945718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice.
    Tang J; Xue W; Xia B; Ren L; Tao W; Chen C; Zhang H; Wu R; Wang Q; Wu H; Duan J; Chen G
    Sci Rep; 2015 Aug; 5():13573. PubMed ID: 26315757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antidepressant-like effect of alarin is related to TrkB-mTOR signaling and synaptic plasticity.
    Zhuang F; Li M; Gao X; Wang Y; Wang D; Ma X; Ma T; Gu S
    Behav Brain Res; 2016 Oct; 313():158-171. PubMed ID: 27374162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ketamine administration on mTOR and reticulum stress signaling pathways in the brain after the infusion of rapamycin into prefrontal cortex.
    Abelaira HM; Réus GZ; Ignácio ZM; Dos Santos MA; de Moura AB; Matos D; Demo JP; da Silva JB; Michels M; Abatti M; Sonai B; Dal Pizzol F; Carvalho AF; Quevedo J
    J Psychiatr Res; 2017 Apr; 87():81-87. PubMed ID: 28017918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of antidepressant drugs on mTOR signalling in rat hippocampal neurons.
    Park SW; Lee JG; Seo MK; Lee CH; Cho HY; Lee BJ; Seol W; Kim YH
    Int J Neuropsychopharmacol; 2014 Nov; 17(11):1831-46. PubMed ID: 24901414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.
    Hara H; Suzuki A; Kunugi A; Tajima Y; Yamada R; Kimura H
    Pharmacol Biochem Behav; 2021 Dec; 211():173289. PubMed ID: 34655652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The involvement of PI3K/Akt/mTOR/GSK3β signaling pathways in the antidepressant-like effect of AZD6765.
    Neis VB; Moretti M; Rosa PB; Dalsenter YO; Werle I; Platt N; Kaufmann FN; Rosado AF; Besen MH; Rodrigues ALS
    Pharmacol Biochem Behav; 2020 Nov; 198():173020. PubMed ID: 32861641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.